Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03241121
Other study ID # 2017-00487
Secondary ID PZ00P3-167826SSE
Status Completed
Phase N/A
First received
Last updated
Start date September 29, 2017
Est. completion date March 31, 2022

Study information

Verified date May 2022
Source University of Lausanne Hospitals
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

SwissChronoFood - Study of eating patterns with a smartphone app and the metabolic effects of time restricted feeding in metabolic syndrome The purpose of this study is to assess eating patterns among teenagers and adults with a new method, going beyond the pen-and-paper food diaries, and to investigate whether time restricted feeding leads to weight loss, improvement in lipid and glucose metabolism in individuals with components of the metabolic syndrome


Description:

The prevalence of the metabolic syndrome (MS) is increasing worldwide, due to the progression of its different components (central obesity, elevated blood pressure, impaired glucose tolerance and dyslipidemia), as well as the often associated liver steatosis. One way to tackle the obesity epidemic is to intervene early at the onset in childhood and teenage years - before cardio-metabolic complications have occurred. However, lifestyle programs targeting this age group had limited success in the current obesogenic environment. In particular, weight loss is a key factor in controlling all MS components, yet it is difficult to maintain over time. Time restricted feeding (TRF) is an approach that emphasizes energy intake limited to certain windows of time within the 24-hour cycle without restrictions on calories or macronutrients. This has emerged as an appealing approach to reduce body weight while improving lipid profile and glucose metabolism. However, TRF has been mostly studied in animals and long-term prospective data on its efficacy and mechanisms in humans is lacking. Prior to the intervention, the investigators will assess the eating patterns of participants with an innovative smartphone application ('app') which is less intrusive and more reliable than food diaries/questionnaires to assess eating behavior and patterns. In this project, the investigators will assess eating patterns among teenagers and adults, and investigate whether a controlled TRF intervention leads to beneficial changes in MS components. Study Part 1 uses an epidemiological approach to establish baseline daily eating behavior, physical activity patterns and sleeping habits over 2 weeks (teenagers) and 4 weeks (adults) using the smartphone app. Those individuals meeting criteria for at least one component of MS and who have eaten for >14 hours per 24-hour cycle will be recruited for Study Part 2. In Part 2, participants will be assigned to TRF or active control groups, and followed in this pragmatic randomized controlled trial for 6 weeks (teenagers) and 6 months (adults) to assess the change in their weight and MS components, as well as liver fat deposits. Study Part 3 will investigate the underlying mechanisms of improved metabolic profile with TRF.


Recruitment information / eligibility

Status Completed
Enrollment 235
Est. completion date March 31, 2022
Est. primary completion date March 31, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 12 Years and older
Eligibility Key inclusion criteria for both observation and intervention phases (Part 1+2): - Age = 12 years - Body mass index = 20 kg/m2 and stable weight (previous 3 months) in adults; BMI = 25th percentile in teenagers - Smartphone compatible with the app (iOS or Android systems) Additional inclusion criteria for the intervention phase (Part 2): - Any component of the metabolic syndrome following the International Diabetes Federation consensus definition - Eating duration >14h during the observation phase Additional inclusion criteria for the mechanistic study (Part 3): - Age 18-40 years, men and pre-menopausal women - BMI 30-40 kg/m2 - In the fasting state (at least 8 hours) Key exclusion criteria for both observation and intervention phases (Part 1+2): - Pregnant and breastfeeding women, plans for maternity during the study - Major illness/fever over the previous month, active cancer - Eating disorder, on a diet / weight management, prior bariatric surgery - Major mental illness, unable to give informed consent - Current shift work or travel abroad planned in the next month Additional exclusion criteria for the intervention phase (Part 2): - Prior cardiovascular event - Major liver, gastrointestinal, renal or endocrine disorder, diabetes mellitus with hypoglycemic drug(s) - Major sleep disorder, centrally acting medication - Lipid lowering drug, hypoglycemic drug, medication affecting the gut Additional exclusion criteria for the mechanistic study (Part 3): - Impaired glucose tolerance (pre-diabetes) or diabetes mellitus - Positive pregnancy test

Study Design


Intervention

Behavioral:
Time restricted feeding
To eat only during a self-selected window of 12 hours, with no advice on nutrition quality, quantity or caloric intake
Regular dietary advices
Regular dietary advices by a trained dietitian or research nurse according to current nutrition guidelines
Device:
Eating patterns
Data collection on eating patterns via the smartphone app

Locations

Country Name City State
Switzerland Inselspital, Klinik für Allgemeine Innere Medizin Bern BE
Switzerland University Hospital of Lausanne (CHUV) Lausanne

Sponsors (2)

Lead Sponsor Collaborator
University of Lausanne Hospitals Salk Institute for Biological Studies

Country where clinical trial is conducted

Switzerland, 

References & Publications (3)

Borloz S, Bucher Della Torre S, Collet TH, Jotterand Chaparro C. Consumption of Ultraprocessed Foods in a Sample of Adolescents With Obesity and Its Association With the Food Educational Style of Their Parent: Observational Study. JMIR Pediatr Parent. 202 — View Citation

Papageorgiou M, Biver E, Mareschal J, Phillips NE, Hemmer A, Biolley E, Schwab N, Manoogian ENC, Gonzalez Rodriguez E, Aeberli D, Hans D, Pot C, Panda S, Rodondi N, Ferrari SL, Collet TH. The effects of time-restricted eating and weight loss on bone metab — View Citation

Phillips NE, Mareschal J, Schwab N, Manoogian ENC, Borloz S, Ostinelli G, Gauthier-Jaques A, Umwali S, Gonzalez Rodriguez E, Aeberli D, Hans D, Panda S, Rodondi N, Naef F, Collet TH. The Effects of Time-Restricted Eating versus Standard Dietary Advice on — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Change in fat mass Body composition as measured by dual energy X-ray absorptiometry (DEXA) From randomization visit to close-out visit (Part 3: 6 months, only adults)
Other Change in fat free mass Body composition as measured by dual energy X-ray absorptiometry (DEXA) From randomization visit to close-out visit (Part 3: 6 months, only adults)
Other Change in diurnal rhythms of cortisol secretion Repeated measurements of cortisol over a 24-hour cycle From randomization visit to close-out visit (Part 3: 6 months, only adults)
Other Change in diurnal rhythms of melatonin secretion Repeated measurements of melatonin over a 24-hour cycle From randomization visit to close-out visit (Part 3: 6 months, only adults)
Other Change in physical activity As measured by actigraphy From randomization visit to close-out visit (Part 3: 6 months, only adults)
Other Change in sleep/wake cycles As measured by actigraphy From randomization visit to close-out visit (Part 3: 6 months, only adults)
Other Eating duration - alternative definition of the primary outcome Alternative definition of eating duration accounting for 2.5-97.5th percentiles of caloric intake over 24 hours, presumably less sensitive to the occasionally forgotten food picture event From baseline visit to end of observation phase (Part 1: 4 weeks for adults, 2 weeks for teenagers)
Primary Eating duration Duration from the first to last caloric intake over 24-hour cycle, collected via the smartphone app.
Note: Key inclusion criterion for the intervention phase (Part 2).
From baseline visit to end of observation phase (Part 1: 4 weeks for adults, 2 weeks for teenagers)
Primary Change of metabolic syndrome components Number of participants with changes in weight and/or lipid profile and/or glucose metabolism in the intervention phase (Part 2).
Note: Changes of the different components will be analyzed separately as secondary outcomes.
From baseline visit to close-out visit (Part 1: 4 weeks for adults, 2 weeks for teenagers; followed by Part 2: 6 months for adults, 6 weeks for teenagers)
Secondary Adherence to TRF intervention After allocation to the TRF arm, assessment of the adherence to the intervention, as measured by eating duration from the first to last caloric intake over 24-hour cycle. From randomization visit to close-out visit (Part 2: 6 months for adults, 6 weeks for teenagers)
Secondary Weight change Part of the composite primary outcome in the intervention phase (Part 2) From baseline visit to close-out visit (Part 1: 4 weeks for adults, 2 weeks for teenagers; followed by Part 2: 6 months for adults, 6 weeks for teenagers)
Secondary Change in lipid profile Part of the composite primary outcome in the intervention phase (Part 2) From baseline visit to close-out visit (Part 1: 4 weeks for adults, 2 weeks for teenagers; followed by Part 2: 6 months for adults, 6 weeks for teenagers)
Secondary Change in glucose metabolism Part of the composite primary outcome in the intervention phase (Part 2) From baseline visit to close-out visit (Part 1: 4 weeks for adults, 2 weeks for teenagers; followed by Part 2: 6 months for adults, 6 weeks for teenagers)
Secondary Change in blood pressure Systolic and diastolic blood pressure From baseline visit to close-out visit (Part 1: 4 weeks for adults, 2 weeks for teenagers; followed by Part 2: 6 months for adults, 6 weeks for teenagers)
Secondary Change in hepatic steatosis / fibrosis score As measured by the Fibroscan device From randomization visit to close-out visit (Part 2: 6 months for adults, 6 weeks for teenagers)
Secondary Change in number of meals per day Temporal analysis of caloric intake events collected by the smartphone app From baseline visit to close-out visit (Part 1: 4 weeks for adults, 2 weeks for teenagers; followed by Part 2: 6 months for adults, 6 weeks for teenagers)
Secondary Change in meal intervals Temporal analysis of caloric intake events collected by the smartphone app From baseline visit to close-out visit (Part 1: 4 weeks for adults, 2 weeks for teenagers; followed by Part 2: 6 months for adults, 6 weeks for teenagers)
Secondary Change in fraction of calories consumed after noon Estimation of caloric content from food pictures collected by the smartphone app From baseline visit to close-out visit (Part 1: 4 weeks for adults, 2 weeks for teenagers; followed by Part 2: 6 months for adults, 6 weeks for teenagers)
Secondary Change in fraction of calories consumed after 6pm Estimation of caloric content from food pictures collected by the smartphone app From baseline visit to close-out visit (Part 1: 4 weeks for adults, 2 weeks for teenagers; followed by Part 2: 6 months for adults, 6 weeks for teenagers)
Secondary Change in eating pattern difference between weekdays and weekends Indirect assessment of different lifestyle habits during weekdays and weekends From baseline visit to close-out visit (Part 1: 4 weeks for adults, 2 weeks for teenagers; followed by Part 2: 6 months for adults, 6 weeks for teenagers)
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2

External Links